Showing 341 - 360 results of 5,248 for search '"Vascular endothelial growth factor"', query time: 0.22s Refine Results
  1. 341
  2. 342
  3. 343

    Two Birds, One Stone: Double Hits on Tumor Growth and Lymphangiogenesis by Targeting Vascular Endothelial Growth Factor Receptor 3 by Ming-Chuan Hsu, Mei-Ren Pan, Wen-Chun Hung

    Published 2019-03-01
    “…Vascular endothelial growth factor receptor 3 (VEGFR3) has been known for its involvement in tumor-associated lymphangiogenesis and lymphatic metastasis. …”
    Get full text
    Article
  4. 344
  5. 345
  6. 346
  7. 347

    Reduced Size of Telangiectatic Capillaries After Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents in Diabetic Macular Edema by Itou J, Furushima K, Haruta M, Kato N, Arai R, Mori K, Ishikawa K, Yoshida S

    Published 2023-01-01
    “…Junichi Itou,1,* Kei Furushima,1,* Masatoshi Haruta,1 Nobuhiro Kato,1 Rikki Arai,1 Kenichiro Mori,2 Keijiro Ishikawa,2 Shigeo Yoshida1 1Department of Ophthalmology, Kurume University School of Medicine, Kurume, Japan; 2Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan*These authors contributed equally to this workCorrespondence: Shigeo Yoshida, Department of Ophthalmology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka, 830-0011, Japan, Tel +81-942-317574, Fax +81-942-370324, Email yoshi@med.kurume-u.ac.jpPurpose: Intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) agents reduces microaneurysms in patients with diabetic macular edema (DME). …”
    Get full text
    Article
  8. 348

    Angiopoietins, Vascular Endothelial Growth Factors and Secretory Phospholipase A<sub>2</sub> in Ischemic and Non-Ischemic Heart Failure by Gilda Varricchi, Stefania Loffredo, Leonardo Bencivenga, Anne Lise Ferrara, Giuseppina Gambino, Nicola Ferrara, Amato de Paulis, Gianni Marone, Giuseppe Rengo

    Published 2020-06-01
    “…Angiopoietins (ANGPTs), vascular endothelial growth factors (VEGFs) and secretory phospholipases A<sub>2</sub> (sPLA<sub>2</sub>s) are proinflammatory mediators and key regulators of endothelial cells. …”
    Get full text
    Article
  9. 349

    Treatment with vascular endothelial growth factor-A worsens cognitive recovery in a rat model of mild traumatic brain injury by Mujun Sun, Tamara L. Baker, Campbell T. Wilson, Rhys D. Brady, Richelle Mychasiuk, Glenn R. Yamakawa, Anh Vo, Trevor Wilson, Stuart J. McDonald, Sandy R. Shultz, Sandy R. Shultz, Sandy R. Shultz

    Published 2022-10-01
    “…The cerebrovascular system is vital to provide oxygen and nutrition to the brain, and a growing body of research indicates that cerebrovascular injury contributes to mTBI symptomatology. Vascular endothelial growth factor-A (VEGF-A) is a potent promoter of angiogenesis and an important modulator of vascular health. …”
    Get full text
    Article
  10. 350
  11. 351
  12. 352
  13. 353

    A systematic review and meta-analysis of preanalytical factors and methodological differences influencing the measurement of circulating vascular endothelial growth factor. by Ulrika Sjöbom, Anders K Nilsson, Hanna Gyllensten, Ann Hellström, Chatarina Löfqvist

    Published 2022-01-01
    “…<h4>Background</h4>Intraocular treatment with antibodies targeting vascular endothelial growth factor (anti-VEGF) inhibits pathological vessel growth in adults and preterm infants. …”
    Get full text
    Article
  14. 354
  15. 355

    Myocardial revascularization effects on vascular endothelial growth factor and transforming growth factor β-1 in coronary heart disease patients by I. V. Sergienko, A. E. Semenova, V. P. Masenko, L. I. Habibullina, S. A. Gabrusenko, V. V. Kukharchuk, Yu. N. Belenkov

    Published 2007-10-01
    “…To assess the dynamics of vascular endothelial growth factor (VEGF), transforming growth factor-beta (TGF- 1) and VEGF receptor Flt-1 (sFlt-1 or sVEGF-R1) levels in coronary heart disease (CHD) patients before and after myocardial revascularization. …”
    Get full text
    Article
  16. 356
  17. 357

    Expression of Vascular Endothelial Growth Factor and Anti-Proliferative Activity of Flaxseed Oil Alone and In Combination with Mefenamic Acid in Cell Lines by Noor Alzubaidy, Hayder Sahib

    Published 2024-03-01
    “…The effects of flaxseed oil alone and its combination with mefenamic acid were tested on the expression of vascular endothelial growth factor genes using real-time polymerase chain reaction. …”
    Get full text
    Article
  18. 358

    Effect of vascular endothelial growth factor inhibitors on choroid in patients with macular choroid neovascular membrane and degenerative myopia .... by V. A. Solomin, D. A. Magaramov, G. F. Kachalina

    Published 2014-07-01
    “…Eyes with mCNV under- went one intravitreal injection of vascular endothelial growth factor inhibitor Ranibizumab 0.5 mg. …”
    Get full text
    Article
  19. 359

    Increased Vascular Endothelial Growth Factor Serum Level and the Role of +936C/T Gene Polymorphism in Chronic Obstructive Pulmonary Disease by Ana Florica Chis, Ruxandra-Mioara Râjnoveanu, Milena Adina Man, Doina Adina Todea, Bogdan Augustin Chis, Bogdan Stancu, Ioan Anton Arghir, Teodora Gabriela Alexescu, Carmen Monica Pop

    Published 2021-12-01
    “…<i>Background and Objectives</i>: Chronic obstructive pulmonary disease (COPD) represents a debilitating disease, with rising morbidity and mortality. Vascular endothelial growth factor (VEGF) plays a major role in angiogenesis, vascular permeability, and airway remodeling. …”
    Get full text
    Article
  20. 360